New Branding Brings FLUVAC INNOVATOR® 4 to the Pfizer Animal Health Stable of Products
Equine Influenza Virus Vaccinations Recommended for At-Risk Equine Populations
By the American Association of Equine Practitioners
FOR IMMEDIATE RELEASE
Equine Resources International, LLC
Madison, NJ (February 8, 2012) - FLUVAC INNOVATOR® 4, a member of the FLUVAC INNOVATOR brand of equine vaccines, is moving to the Pfizer Animal Health label after the acquisition of Wyeth and Fort Dodge Animal Health in 2009. The vaccine is now manufactured by Pfizer Animal Health and features an updated label and packaging.
FLUVAC INNOVATOR 4 vaccines aid in the prevention of equine influenza due to type A2 viruses; equine encephalomyelitis due to Eastern and Western equine encephalomyelitis viruses; and tetanus. These vaccines are adjuvanted with MetaStim for an improved immune response. The American Association of Equine Practitioners (AAEP) recommends equine influenza vaccination every six months for at-risk horses, which includes horses under six years of age, geriatric horses and horses that may be frequently exposed to equine influenza virus (EIV) at shows or other equestrian events1.
"For many years, FLUVAC INNOVATOR has been the trusted choice of veterinarians to help provide protection from equine influenza due to EIV," said Andrea Wright, DVM, MVSc, Marketing Manager, Equine Biologicals for Pfizer Animal Health. "Pfizer Animal Health stands behind the established reputation and efficacy of these vaccines. The FLUVAC INNOVATOR vaccines are available in a wide range of combinations to help provide veterinarians and horse owners with the protection that best suits their horses and situations."
The FLUVAC INNOVATOR vaccines are included in the Equine Immunization Support Guarantee, which provides up to $5,000 for reasonable diagnostic and treatment costs if a horse properly vaccinated by a veterinarian contracts the corresponding equine disease. Disease protection backed by the Equine Immunization Support Guarantee includes infection from West Nile virus, equine influenza virus, tetanus, Eastern equine encephalomyelitis virus, Western equine encephalomyelitis virus, and Venezuelan equine encephalomyelitis virus. Vaccinations must be provided and administered by a licensed veterinarian with an established client-patient relationship to be eligible. For more information on this program, horse owners should contact their veterinarian.
For more information on the FLUVAC INNOVATOR vaccines, contact your Pfizer Animal Health representative or call 1-855-4AH-PFIZER (1-855-424-7349).
About Pfizer Animal Health
Pfizer Animal Health, a business unit of Pfizer Inc., is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, and diagnostic products. Pfizer Animal Health invests more in research and development than any other animal health company. We work to assure a safe, sustainable global food supply from healthy beef and dairy cattle, swine, poultry and fish while helping dogs, cats and horses live healthier longer lives. We strive to be the animal health company that provides full healthcare solutions to veterinarians, livestock producers, and pet owners. To learn more, visit www.us.animalhealth.pfizer.com.
- Equine Influenza (2008). In American Association of Equine Practitioners website. Accessed Jan. 16, 2011 from http://www.aaep.org/equine_influenza.htm
All brands are the property of their respective owners. ©2012 Pfizer Inc. All rights reserved
Editors: Images to accompany this release are available for download
at www.equineresources.com in the Client News section.